From: Pharmacokinetics of phenoxodiol, a novel isoflavone, following intravenous administration to patients with advanced cancer
Patient number
Css (μg/ml)
Time to ss (h)
Acc T1/2 (h)
Cl (L/h)
1*
14.74
3.66
0.73
0.06
2*
32.31
4.00
0.80
0.03
4
13.33
2.00
0.40
0.07
5
14.80
6
12.04
2.33
0.47
0.08
Mean ± SD
17.45 ± 8.38
2.78 ± 0.96
0.56 ± 0.19
0.06 ± 0.01